Neovacs【ALNEV】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.0563

買値

0.0563

売値

0.0623

出来高

147,666

0.0555 日の範囲 0.0755

0.0001 52 週間の範囲 3.15

時価総額

17.488k

前日終値

0.0611

始値

0.0641

時刻

7069

0.0563

最終取引時間

23:56:52

財務取引量

VWAP

平均取引量 (3 か月)

92,934

発行済株式数

310,613

配当利回り

PER

0.00

1 株当たり利益 (EPS)

-28.15

歳入

534k

純利益

-8.74M

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.neovacs.com

本社

Suresnes, Hauts-de-seine, Fra

設立

Neovacs is listed in the Biological Pds,ex Diagnstics sector of the ユーロネクスト with ticker ALNEV. The last closing price for Neovacs was 0.06 €. Over the last year, Neovacs shares have traded in a share price range of 0.0001 € to 3.15 €.

Neovacs currently has 310,613 shares in issue. The market capitalisation of Neovacs is 18,978.45 € . Neovacs has a price to earnings ratio (PE ratio) of 0.00.

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS COMMUNIQUE DE PRESSE ·...

NEOVACS :

NEOVACS : COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE L’OUVERTURE D’UNE PROCÉDURE DE REDRESSEMENT...

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Paris et...

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ...

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019 Paris et Boston, le 30 octobre 2019 – 17 : 45 CET - NÉOVACS (Euronext Paris :...

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019 COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE SES...

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0237	-29.625	0.08	0.0851	0.0551	123110	0.06528949	DE
4	-0.0447	-44.2574257426	0.101	0.15	0.0551	202413	0.09321765	DE
12	-1.1637	-95.3852459016	1.22	1.4	0.0551	92934	0.15293695	DE
26	0.0556	7942.85714286	0.0007	3.15	0.0001	18950445	0.00067117	DE
52	-0.9637	-94.4803921569	1.02	3.15	0.0001	14900797	0.0018193	DE
156	-1.0937	-95.1043478261	1.15	3.2	0.0001	21912520	0.00267359	DE
260	-0.0017	-2.93103448276	0.058	4.399	0.0001	64513469	0.00704304	DE

ALNEV - Frequently Asked Questions (FAQ)

What is the current Neovacs share price?

The current share price of Neovacs is 0.0563 €

How many Neovacs shares are in issue?

Neovacs has 310,613 shares in issue

What is the market cap of Neovacs?

The market capitalisation of Neovacs is EUR 18.98k

What is the 1 year trading range for Neovacs share price?

Neovacs has traded in the range of 0.0001 € to 3.15 € during the past year

What is the cash to sales ratio of Neovacs?

The cash to sales ratio of Neovacs is 0.03

What is the reporting currency for Neovacs?

Neovacs reports financial results in EUR

What is the latest annual turnover for Neovacs?

The latest annual turnover of Neovacs is EUR 534k

What is the latest annual profit for Neovacs?

The latest annual profit of Neovacs is EUR -8.74M

What is the registered address of Neovacs?

The registered address for Neovacs is 14, RUE DE LA REPUBLIQUE, SURESNES, HAUTS-DE-SEINE, 92150

What is the Neovacs website address?

The website address for Neovacs is www.neovacs.com

Which industry sector does Neovacs operate in?

Neovacs operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

銘柄コード	株価	出来高
SGDDSSpineguard DS	0.0004 € (300.00%)	1.18M
MLCOTCoretech 5	0.05 € (96.08%)	2.15k
NICBSNicox SA	0.0199 € (51.91%)	2.08k
PHRPHarol SGPS SA	0.088 € (26.80%)	24.78M
BNBSTonner Drones	0.0025 € (25.00%)	3.15M
TDBSTonner Drones	0.0059 € (-27.16%)	2.54M
ABLDABL Diagnostics	5.60 € (-22.76%)	4.5k
DMSBSDiagnostic Medical Systems	0.004 € (-20.00%)	1.3k
LUDSLucibel DS	0.0004 € (-20.00%)	389.42k
ALTDTonner Drones	0.0228 € (-16.79%)	54.15M
ATOAtos SE	0.0041 € (-2.38%)	405.72M
ALCYBCybergun	0.0003 € (0.00%)	250.79M
BCPBanco Comercial Portugues SA	0.5528 € (4.22%)	67.45M
ALEUPEuroplasma	0.0188 € (-5.53%)	65.08M
ALTDTonner Drones	0.0228 € (-16.79%)	54.15M

銘柄コード

株価

出来高

ATOAtos SE

0.0041 €

(-2.38%)

405.72M

ALCYBCybergun

0.0003 €

(0.00%)

250.79M

BCPBanco Comercial Portugues SA

0.5528 €

(4.22%)

67.45M

ALEUPEuroplasma

0.0188 €

(-5.53%)

65.08M

ALTDTonner Drones

0.0228 €

(-16.79%)

54.15M

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Neovacs (ALNEV)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

Neovacs について

ALNEV 最新ニュース

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS

NEOVACS :

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER

ALNEV - Frequently Asked Questions (FAQ)

ムーバー

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Neovacs (ALNEV) 銘柄情報

Neovacs (ALNEV)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

Neovacs について

ALNEV 最新ニュース

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS

NEOVACS :

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER

ALNEV - Frequently Asked Questions (FAQ)

ムーバー

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

広告を削除する